Alzamend Neuro ALZN 深 滬
交易中 08-20 11:14:11 美东时间
1.55
+0.030
+1.97%
華盛通- 最 高1.59
- 今 開1.56
- 成交量 3.76万股
- 最 低 1.5318
- 昨 收 1.52
- 總市值 742.69万
- 52周最高 2.68
- 市盈率 靜 --
- 換手率 0.79%
- 52周最低 0.84
- 委 比 77.51%
- 總股本 479.15万
- 歷史最高 45292.50
- 量 比 2.37
- 振 幅 3.83%
- 歷史最低 0.84
- 每 手 1
- 風險率 0.54%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股前瞻 | 史诗级“轧空”来袭！比特币升破7.2万美元；业绩股齐遇冷！沃尔玛盘前大跌逾6%，阿里、网易均跌近4%
史诗级“轧空”来袭！比特币升破7.2万美元，Strategy盘前涨逾9%；业绩股齐遇冷！沃尔玛盘前大跌逾6%，阿里、网易均跌近4%；SK海力士达成重要劳资协议！或加薪逾6%>>
今天 20:22
美股大行评级 | 潜在涨幅1610.53%！Ascendiant Capital上调Alzamend Neuro目标价至26美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Alzamend Neuro"买入"评级，目标价从25美元升至26美元；Tigress Financial：维持Legence"买入"评级，目标价从125美元升至130美元
今天 08:39
Palo Alto To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler raised the price target for Mercury Systems Inc (NASDAQ:MRCY) from $126 to $131. Piper Sandler a...
08-19 20:23
Ascendiant Capital Maintains Buy on Alzamend Neuro, Raises Price Target to $26
Ascendiant Capital analyst Edward Woo maintains Alzamend Neuro (NASDAQ:ALZN) with a Buy and raises the price target from $25 to $26.
08-19 18:06
Alzamend Neuro's Phase 1/2A Lithium Imaging Data Accepted for Oral Presentation at ISMRM Workshop
ISMRM Workshop on Beyond Protons: Challenges and Advances in X-Nuclei MR will be held September 28 – October 1, 2026 at the Universitat Oberta de Catalunya (UOC) in Barcelona, Spain Presentation will report first-of-its-kind pharmacokinetic imaging results from Phase 1/2A trial of AL001, Alzamend's ...
08-18 20:06
Alzamend Neuro Signs $25M Securities Purchase Agreement With Ault Lending; Alzamend Receives $7.5M In Gross Proceeds Form Initial Tranche
Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar disorder ("BD"), major depressive disorder ("MDD") and post-traumatic stress disorder ("PTSD"), announce...
08-04 20:12
Alzamend Neuro Announces Passing of Board Director
An update from Alzamend Neuro ( ($ALZN) ) is now available. Alzamend Neuro, Inc...
07-22 05:09
美股夜盘 | 707 Cayman Holdings涨154.16%，Globavend Holdings Ltd.涨22.92%
因立夫涨-43.13%；柏雅国际涨-17.28%；Core Al涨-6.95%
07-01 08:05
Alzamend Neuro Announces Pharmacodynamic Findings From Brain Magnetic Resonance Spectroscopy Analysis Conducted In Healthy Human Subjects In Trial Conducted At Massachusetts General Hospital
Potentially Distinct Brain Profile: Across multiple brain regions, AL001 and lithium carbonate appeared to trend in opposite directions in brain chemistry measures, suggesting that AL001 may interact with the brain in a
04-07 20:15
